Share:
  • Title:Alan K. Burnett | ISAL 2019 | Gemtuzumab ozogamicin in CBF AML
  • Duration: 3:44
  • Plays: 271 views
  • Published: 5 years ago
Download MP3
Download MP4


Simillar Videos

In the AML treatment landscape, when is anti-infection and anti-fungal prophylaxis recommended?▶️ 5:29
In The Aml Treatment Landscape, When Is Anti-infection And Anti-fungal Prophylaxis Recommended? 271 views • 1 year ago
How can we improve efficacy of CAR T-cell therapy in AML?▶️ 4:46
How Can We Improve Efficacy Of Car T-cell Therapy In Aml? 271 views • 3 years ago
Should MRD negativity post remission impact treatment decisions in ELN-intermediate risk AML?▶️ 11:54
Should Mrd Negativity Post Remission Impact Treatment Decisions In Eln-intermediate Risk Aml? 271 views • 2 months ago
The impact of the 5th WHO classification and ICC of AML on diagnosis and treatment of HR AML▶️ 12:22
The Impact Of The 5th Who Classification And Icc Of Aml On Diagnosis And Treatment Of Hr Aml 271 views • 3 months ago
“How I treat” a patient with AML in remission after intensive chemotherapy not proceeding to HSCT▶️ 9:07
“how I Treat” A Patient With Aml In Remission After Intensive Chemotherapy Not Proceeding To Hsct 271 views • 10 days ago